Senseonics Holdings (SENS) Cash from Financing Activities (2014 - 2026)
Senseonics Holdings (SENS) reported Cash from Financing Activities of $3.4 million for Q1 2026, down 44.32% year-over-year from $6.1 million in Q1 2025, and up 210.29% quarter-over-quarter from $1.1 million in Q4 2025.
Senseonics Holdings (SENS) Cash from Financing Activities (2014 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has 13 years of Cash from Financing Activities data on file, last reported at $3.4 million in Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at $3.4 million, down 44.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $75.5 million (up 229.37% YoY), and the FY2025 annual result was $78.2 million, up 191.42% from the prior year.
- Cash from Financing Activities improved to $3.4 million in Q1 2026 per SENS's latest filing, from $1.1 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $71.1 million in Q2 2025 and troughed at -$1.8 million in Q2 2022.
- A 5-year average of $10.0 million and a median of $5.5 million in 2023 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities sank 118.42% in 2024, then soared 7084.77% in 2025.
- A 5-year view of Cash from Financing Activities shows it stood at $10.3 million in 2022, then slumped by 111.39% to -$1.2 million in 2023, then surged by 1294.48% to $14.1 million in 2024, then plunged by 92.2% to $1.1 million in 2025, then soared by 210.29% to $3.4 million in 2026.
- Business Quant data shows SENS's Cash from Financing Activities at $3.4 million in Q1 2026, $1.1 million in Q4 2025, and -$134000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Senseonics Holdings | 309.99 Mn | 245.67 Mn | 6.94 Mn | 3.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.41 Mn |
| Mar 31, 2026 | 3.41 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | -134,000.00 |
| Sep 30, 2025 | -134,000.00 |
| Jun 30, 2025 | 71.11 Mn |
| Jun 30, 2025 | 71.11 Mn |
| Mar 31, 2025 | 6.12 Mn |
| Mar 31, 2025 | 6.12 Mn |
| Dec 31, 2024 | 14.07 Mn |
| Dec 31, 2024 | 14.07 Mn |
| Sep 30, 2024 | 3.74 Mn |
| Sep 30, 2024 | 3.74 Mn |
| Jun 30, 2024 | -1.02 Mn |
| Jun 30, 2024 | -1.02 Mn |
| Mar 31, 2024 | 10.03 Mn |
| Mar 31, 2024 | 10.03 Mn |
| Dec 31, 2023 | -1.18 Mn |
| Dec 31, 2023 | -1.18 Mn |